or Try an Advanced Search...

    Technical Analysis for AEON - AEON Biopharma, Inc.

    Grade Last Price % Change Price Change
    F 5.07 19.29% 0.82
    AEON closed up 19.29 percent on Friday, April 26, 2024, on 1.72 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical AEON trend table...
    Date Alert Name Type % Chg
    Slingshot Bearish Bearish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 19.29%
    Oversold Stochastic Weakness 19.29%
    Wide Bands Range Expansion 26.43%
    Oversold Stochastic Weakness 26.43%
    Wide Bands Range Expansion 17.91%
    Oversold Stochastic Weakness 17.91%
    Older End-of-Day Signals for AEON ...

       Recent Intraday Alerts

    Alert Time
    Possible Pocket Pivot about 12 hours ago
    1.5x Volume Pace about 13 hours ago
    Up 5% about 16 hours ago
    Up 10% about 16 hours ago
    60 Minute Opening Range Breakout about 17 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    AEON Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Botulinum Toxin Dystonia

    Is AEON a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 19 Here's Why AEON Biopharma, Inc. (AEON) Is a Great 'Buy the Bottom' Stock Now
    Mar 31 CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants
    Mar 29 AEON Biopharma Announces Redemption of Public Warrants
    Mar 29 AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
    Mar 19 AEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Migraine
    Mar 19 AEON Biopharma Announces $15 Million Financing Transaction and Termination of Forward Purchase Agreements
    Dec 12 AEON Biopharma Completes Enrollment in Phase 2 Study of ABP-450 (prabotulinumtoxinA) for Preventive Treatment of Chronic Migraine
    Nov 13 AEON Biopharma Reports Third Quarter 2023 Financial Results
    See more AEON news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.17
    52 Week Low 3.37
    Average Volume 77,563
    200-Day Moving Average 7.25
    50-Day Moving Average 10.02
    20-Day Moving Average 6.76
    10-Day Moving Average 5.43
    Average True Range 1.04
    RSI (14) 34.64
    ADX 34.11
    +DI 15.60
    -DI 33.92
    Chandelier Exit (Long, 3 ATRs) 9.82
    Chandelier Exit (Short, 3 ATRs) 6.91
    Upper Bollinger Bands 9.95
    Lower Bollinger Band 3.57
    Percent B (%b) 0.23
    BandWidth 94.32
    MACD Line -1.65
    MACD Signal Line -1.45
    MACD Histogram -0.1973
    Fundamentals Value
    Market Cap 188.4 Million
    Num Shares 37.2 Million
    EPS -2.39
    Price-to-Earnings (P/E) Ratio -2.12
    Price-to-Sales 97.16
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.48
    Resistance 3 (R3) 6.32 5.70 6.25
    Resistance 2 (R2) 5.70 5.34 5.78 6.17
    Resistance 1 (R1) 5.38 5.12 5.54 5.54 6.09
    Pivot Point 4.76 4.76 4.84 4.84 4.76
    Support 1 (S1) 4.44 4.40 4.60 4.60 4.05
    Support 2 (S2) 3.82 4.18 3.90 3.97
    Support 3 (S3) 3.50 3.82 3.90
    Support 4 (S4) 3.66